Stony Brook Study on the Role of DNA Amplification in Cancer Chemoresistance Leverages KromaTiD dGH in-Site™ Technology ...Middle East

LONGMONT, Colo., Feb. 6, 2024 /PRNewswire/ -- A Stony Brook University team of researchers led by Gábor Balázsi, PhD, has identified DNA amplification as a major cause of drug resistance in engineered mammalian cell lines and has identified a novel approach to overcome it in those cells...

Hence then, the article about stony brook study on the role of dna amplification in cancer chemoresistance leverages kromatid dgh in site technology was published today ( Tuesday 06/02/2024 - 04:40 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Stony Brook Study on the Role of DNA Amplification in Cancer Chemoresistance Leverages KromaTiD dGH in-Site™ Technology )

Also on site :

• ‘The Angry Birds Movie 3’ Unpacked by VFX Supervisor, Including Red’s Redesign and Character-Effects Automation: ’He’s Similar by Choice’
• Fleetwood Mac Crowned ‘As Talented as Any Band’ After Beating Led Zeppelin on Best Bands of All Time List
• How Hegseth’s Pentagon tenure is shaping his possible political future